|
|
TTD
Target ID:
TTDC00338
Target
Information |
Name | Activin receptor-like kinase-1 | Type of target | Clinical trial target | Synonyms | ACVRL1 | ACVRLK1 | ALK-1 | Activin receptor-like kinase 1 | SKR3 | Serine/threonine-protein kinase receptor R3 | TGF-B superfamily receptor type I | TSR-I | Disease | Advanced cancers, age-related macular degeneration [ICD9: 140-229, 362.50 ICD10: C00-C96, H35.3] | [1] | Drug(s) | ACE-041 |  | Phase I | Advanced cancers, age-related macular degeneration | [1] | PF-03446962 |  | Phase I | Solid Tumors | | UniProt ID | P37023 | PDB Structure | 3MY0. | Function | On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for TGF-beta. May bind activin as well. | Sequence | MTLGSPRKGLLMLLMALVTQGDPVKPSRGPLVTCTCESPHCKGPTCRGAWCTVVLVREEG
RHPQEHRGCGNLHRELCRGRPTEFVNHYCCDSHLCNHNVSLVLEATQPPSEQPGTDGQLA
LILGPVLALLALVALGVLGLWHVRRRQEKQRGLHSELGESSLILKASEQGDSMLGDLLDS
DCTTGSGSGLPFLVQRTVARQVALVECVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWF
RETEIYNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLAL
RLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSD
YLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVED
YRPPFYDVVPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARL
TALRIKKTLQKISNSPEKPKVIQ
| Inhibitor | ACE-041 |  | [1] |
Cross References |
3D Structure
Related Literature
On-Line
Medical Dictionary |
Ref 1 | 2011 Pipeline of Acceleron Pharma. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|